Firms

Danaher Ventures
Danaher Ventures is Danaher Corporation’s corporate investment subsidiary, identified as Danaher Ventures LLC in the parent’s own transaction announcements. Established in2017, it finances and develops early-stage businesses in biotechnology, diagnostics, scientific tools and data science. It supports investment partnerships and venture creation through the Pioneer Program, combining corporate capital and operating expertise. These operating mechanisms are not evidence of separate outside-LP funds or a cash fund close. Its verified AI-related investments include Automata’s robotic laboratory infrastructure and Innovaccer’s healthcare data and AI platform; primary sources also identify BlueWhale Bio’s cell-therapy manufacturing work and Signify Bio’s nucleic-acid protein therapeutics. Portfolio affiliations do not establish present ownership or undisclosed ticket sizes. The parent corporation, academic research collaborations, subsidiary instrument businesses and venture unit are distinguished. Leadership is date-qualified: Murali Venkatesan’s own recent departure announcement supersedes the website’s continuing head label, while Samuel Ngai is explicitly a former Asia head in2025 organizer sources. Other recorded affiliations retain their published dates. No successor, complete current staff directory, external-LP final close or unit-wide capital total is verified. The logo is the authentic Danaher wordmark used on the unit’s own webpage.
- Founded
- 2017
- Type
- Venture capital
Funds0
No funds on record yet.






